Bevantolol is a beta-blocker medication used to treat high blood pressure, angina, and other heart-related conditions. It works by blocking certain receptors in the body, thus decreasing the force and rate of heart contractions and reducing blood pressure. Bevantolol is available in both oral and injectable forms. Common side effects include dizziness, fatigue, and nausea. It was discovered and developed by Warner-Lambert[3] but in January 1989 the company announced that it had withdrawn the New Drug Application; the company's chairman said: "Who needs the 30th beta blocker?" As of 2016 it wasn't marketed in the US, UK, or Europe
Bevantolol was a drug candidate for angina pectoris and hypertension, meaning it was undergoing development and testing but never reached the market. It possessed properties of both a beta blocker and a calcium channel blocker, offering a potentially unique approach to treating these conditions.
Here's a summary of Bevantolol:
- Type: Beta-1 adrenoceptor antagonist and calcium channel blocker (dual mechanism)
- Intended uses: Treatment of angina pectoris (chest pain) and hypertension (high blood pressure)
- Status: Development discontinued in 1989, not available in the US, UK, or Europe
Reason for discontinuation: The developer, Warner-Lambert, cited a saturated market for beta blockers as the reason for withdrawing the New Drug Application.
It's important to note:
- Bevantolol never received official approval for medical use.
- Information about Bevantolol is limited due to its developmental status.
- Always consult a healthcare professional for information and treatment regarding medical conditions. They can advise you on approved and available medications suitable for your specific needs.